Cargando…

Association between use of liraglutide and liver fibrosis in patients with type 2 diabetes

OBJECTIVE: Patients with type 2 diabetes have a high risk of non-alcoholic fatty liver disease (NAFLD) and related liver fibrosis. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have demonstrated efficacy in improving NAFLD, while their effectiveness on liver fibrosis is limited in type 2 diab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Yijiong, Zhen, Qin, Ding, Xiaoying, Shen, Tingting, Liu, Fang, Wang, Yufan, Zhang, Qidi, Lin, Renkun, Chen, Lili, Peng, Yongde, Fan, Nengguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399467/ https://www.ncbi.nlm.nih.gov/pubmed/36034438 http://dx.doi.org/10.3389/fendo.2022.935180

Ejemplares similares

Interrelation between the lipid accumulation product index and diabetic kidney disease in patients with type 2 diabetes mellitus
por: Tang, Min, et al.
Publicado: (2023)

Association of the Non‐Alcoholic Fatty Liver Disease Fibrosis Score with subclinical myocardial remodeling in patients with type 2 diabetes: A cross‐sectional study in China
por: Fan, Nengguang, et al.
Publicado: (2021)

Sex-Specific Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients
por: Fan, Nengguang, et al.
Publicado: (2016)

Helicobacter pylori Infection Is Not Associated with Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study in China
por: Fan, Nengguang, et al.
Publicado: (2018)

Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study
por: Fan, Nengguang, et al.
Publicado: (2019)

Consistently Low Levels of Osteocalcin From Late Pregnancy to Postpartum Are Related to Postpartum Abnormal Glucose Metabolism in GDM Patients
por: Gong, Yujia, et al.
Publicado: (2022)

Prevalence of and risk factors for diabetic retinopathy in residents with different types of abnormal glucose metabolism with or without hypertension: A suburban community-based cross-sectional study
por: Ma, Yuhang, et al.
Publicado: (2022)

Rapamycin Improves Palmitate-Induced ER Stress/NFκB Pathways Associated with Stimulating Autophagy in Adipocytes
por: Yin, Jiajing, et al.
Publicado: (2015)

Palmitate induces endoplasmic reticulum stress and autophagy in mature adipocytes: Implications for apoptosis and inflammation
por: YIN, JIAJING, et al.
Publicado: (2015)

Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease
por: Luo, Yunchen, et al.
Publicado: (2021)

Serum spexin differed in newly diagnosed type 2 diabetes patients according to body mass index and increased with the improvement of metabolic status
por: Gu, Liping, et al.
Publicado: (2022)

The Discovery and Development of Liraglutide and Semaglutide
por: Knudsen, Lotte Bjerre, et al.
Publicado: (2019)

Heat shock protein 70 promotes lipogenesis in HepG2 cells
por: Zhang, Jielei, et al.
Publicado: (2018)

Fat mass and obesity–associated protein promotes liver steatosis by targeting PPARα
por: Wei, Xiaohui, et al.
Publicado: (2022)

Effects of dehydroepiandrosterone alone or in combination with a high-fat diet and antibiotic cocktail on the heterogeneous phenotypes of PCOS mouse models by regulating gut microbiota
por: Wang, Xuejiao, et al.
Publicado: (2022)

The change of non-alcoholic fatty liver disease is associated with risk of incident diabetes
por: Chen, Congling, et al.
Publicado: (2023)

Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes
por: Su, Yu, et al.
Publicado: (2023)

Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes
por: Hansen, Christian Stevns, et al.
Publicado: (2019)

Factors associated with gastrointestinal side effects after liraglutide treatment for type 2 diabetes
por: Wu, Hao, et al.
Publicado: (2023)

Stressed Liver and Muscle Call on Adipocytes with FGF21
por: Luo, Yongde, et al.
Publicado: (2013)

A Diabetic Patient Complicated With Pancreatic Cancer After Using Liraglutide: A Case Report
por: Wu, Shengjie, et al.
Publicado: (2021)

Role of Dapagliflozin and Liraglutide on Diabetes-Induced Cardiomyopathy in Rats: Implication of Oxidative Stress, Inflammation, and Apoptosis
por: El-Shafey, Mohamed, et al.
Publicado: (2022)

Metabolic remodeling of glycerophospholipids acts as a signature of dulaglutide and liraglutide treatment in recent-onset type 2 diabetes mellitus
por: Du, Juan, et al.
Publicado: (2023)

Case Report: Liraglutide for Weight Management in Beckwith-Wiedemann Syndromic Obesity
por: Caputo, Marina, et al.
Publicado: (2021)

Liraglutide Inhibits Osteoclastogenesis and Improves Bone Loss by Downregulating Trem2 in Female Type 1 Diabetic Mice: Findings From Transcriptomics
por: Yu, Jie, et al.
Publicado: (2021)

The Effect of Liraglutide on Weight Loss in Women with Polycystic Ovary Syndrome: An Observational Study
por: Rasmussen, Christina B., et al.
Publicado: (2014)

Association between Chinese visceral adiposity index and metabolic-associated fatty liver disease in Chinese adults with type 2 diabetes mellitus
por: Tang, Min, et al.
Publicado: (2022)

Follistatin-Like 1: A Potential Mediator of Inflammation in Obesity
por: Fan, Nengguang, et al.
Publicado: (2013)

The product of waist and neck circumference outperforms traditional anthropometric indices in identifying metabolic syndrome in Chinese adults with type 2 diabetes: a cross-sectional study
por: Huang, Yunhong, et al.
Publicado: (2021)

Associations of advanced liver fibrosis with heart failure with preserved ejection fraction in type 2 diabetic patients according to obesity and metabolic goal achievement status
por: Jiang, Wangyan, et al.
Publicado: (2023)

Evolution of Hepatic Steatosis to Fibrosis and Adenoma Formation in Liver-Specific Growth Hormone Receptor Knockout Mice
por: Fan, Yong, et al.
Publicado: (2014)

Effectiveness, Safety, and Patient Satisfaction of Liraglutide in Type 2 Diabetic Patients
por: Zameer, Rafia, et al.
Publicado: (2020)

High-Fiber Diet or Combined With Acarbose Alleviates Heterogeneous Phenotypes of Polycystic Ovary Syndrome by Regulating Gut Microbiota
por: Wang, Xuejiao, et al.
Publicado: (2022)

Liraglutide Activates Type 2 Deiodinase and Enhances β3-Adrenergic-Induced Thermogenesis in Mouse Adipose Tissue
por: Oliveira, Fernanda C. B., et al.
Publicado: (2022)

Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
por: Xing, Chuan, et al.
Publicado: (2022)

High-Sensitive CRP Correlates With the Severity of Liver Steatosis and Fibrosis in Obese Patients With Metabolic Dysfunction Associated Fatty Liver Disease
por: Zhu, Cuiling, et al.
Publicado: (2022)

Overexpression of IGF2 affects mouse weight and glycolipid metabolism and IGF2 is positively related to macrosomia
por: Zhang, Qidi, et al.
Publicado: (2023)

Exploring Cardio-Metabolic Effects of Liraglutide in Patients With Type 2 Diabetes Through a Proteomic Approach
por: Ekhzaimy, Aishah Ali, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population
por: Ciardullo, Stefano, et al.
Publicado: (2021)

Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease
por: Lee, Chi-Ho, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sti1t4skl2mhblur6btdpvvjk4